These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2477118)

  • 1. Pharmacodynamics and proposed mechanism of therapeutic action and host toxicity of 9-beta-D-arabinofuranosyl-2-fluoroadenine monophosphate (F-araAMP) in P388 murine leukemia-bearing mice.
    Avramis VI
    Cancer Invest; 1989; 7(2):129-37. PubMed ID: 2477118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of 9-beta-D-arabinosyl-2-fluoroadenine-5'-phosphate by mice bearing P388 leukemia.
    Avramis VI; Plunkett W
    Cancer Drug Deliv; 1983; 1(1):1-10. PubMed ID: 6085754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI; Plunkett W
    Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.
    Noker PE; Duncan GF; El Dareer SM; Hill DL
    Cancer Treat Rep; 1983 May; 67(5):445-56. PubMed ID: 6189605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-fluoro-ATP: a toxic metabolite of 9-beta-D-arabinosyl-2-fluoroadenine.
    Avramis VI; Plunkett W
    Biochem Biophys Res Commun; 1983 May; 113(1):35-43. PubMed ID: 6860342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemia.
    Danhauser L; Plunkett W; Liliemark J; Gandhi V; Iacoboni S; Keating M
    Leukemia; 1987 Sep; 1(9):638-43. PubMed ID: 3478543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
    Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM
    Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM; Rustum YM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.
    Parker WB; Shaddix SC; Chang CH; White EL; Rose LM; Brockman RW; Shortnacy AT; Montgomery JA; Secrist JA; Bennett LL
    Cancer Res; 1991 May; 51(9):2386-94. PubMed ID: 1707752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of 3,4-disuccinyldianhydrogalactitol, N-nitrosourea and their combination on DNA synthesis in normal and mouse P388 tumor cells].
    Sokolova IS; Veres Z; Jakus J; Otvos LL; Gorbacheva LB
    Izv Akad Nauk SSSR Biol; 1989; (4):527-33. PubMed ID: 2794230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy.
    Gandhi V; Estey E; Du M; Keating MJ; Plunkett W
    Clin Cancer Res; 1997 Sep; 3(9):1539-45. PubMed ID: 9815841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphoma.
    Danhauser L; Plunkett W; Keating M; Cabanillas F
    Cancer Chemother Pharmacol; 1986; 18(2):145-52. PubMed ID: 2431803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells.
    Tseng WC; Derse D; Cheng YC; Brockman RW; Bennett LL
    Mol Pharmacol; 1982 Mar; 21(2):474-7. PubMed ID: 7048062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells.
    Gandhi V; Plunkett W
    Cancer Res; 1988 Jan; 48(2):329-34. PubMed ID: 3335008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
    Gandhi V; Estey E; Du M; Nowak B; Keating MJ; Plunkett W
    Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 9-Beta-D-arabinofuranosyladenine 5'-monophosphate (araAMP) is converted directly to its antivirally active 5'-triphosphate form by 5-phosphoribosyl-1-pyrophosphate (PRPP) synthetase.
    Balzarini J; De Clercq E
    Biochem Biophys Res Commun; 1990 Dec; 173(3):781-7. PubMed ID: 1702630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase.
    Parker WB; Allan PW; Hassan AE; Secrist JA; Sorscher EJ; Waud WR
    Cancer Gene Ther; 2003 Jan; 10(1):23-9. PubMed ID: 12489025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of decrease of protein synthesis by sodium cyanate in murine P388 leukemia cells.
    Lazarus P; Panasci LC
    Cancer Res; 1987 Oct; 47(19):5102-7. PubMed ID: 3621195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
    Kühl JS; Sikic BI; Blume KG; Chao NJ
    Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.